# Product Improvement 009 — Step 03B: Versioned Prescription Branding

2026-11-01 (America/Toronto). **SATISFIED — LOCALLY VERIFIED.** Implementation, disposable-database migration/finalization tests, focused regressions, isolated builds and synthetic PDF/image review completed. **Not persistently migrated, deployed or runtime accepted.**

Branch `main`, read from local HEAD. The one requested initial Git-status inspection showed only the owner's untracked `009-step03-prescription-printing-assessment.md`; that report remains untouched. No subsequent Git operation, staging, commit or remote operation occurred. The owner's Step 03B request explicitly extends [Step 03A](009-step03-prescription-printing-assessment.md) to both signed and unsigned finalization.

## Implementation and snapshot contract

Existing output conventions were confirmed before choosing **PrescriptionOutputVersion 3**:

| Snapshot | Current reader behavior |
| --- | --- |
| No output marker / legacy snapshots, including independent-refill/date/generic-name extensions | Existing legacy HTML/PDF path, unchanged |
| PrescriptionOutputVersion 2 | Existing `PrescriptionOutputService.Compose` and prescription header/footer path, unchanged |
| PrescriptionOutputVersion 3, PrescriptionContentVersion 2 | Frozen shared branding plus the existing signed clinical body and signature/occurrence footer |
| PrescriptionOutputVersion 3, PrescriptionContentVersion 1 | Frozen shared branding plus the existing unsigned legacy clinical body; no electronic-signature claim |

New version-3 snapshots append `PrescriptionContentVersion` and an immutable `Branding` object. Signed snapshots retain their existing `SignatureVersion`, signer identity/time, clinical fields and independent version markers. Unsigned snapshots retain their existing clinical serialization and have no signature marker. Moving to version 3 does not enrich unsigned output with clinical fields that the prior unsigned snapshot never captured.

`Branding.Version = 1` contains Name, AddressLine1/2, City, Province, PostalCode, Phone, Fax, Email, Country, PngBase64, Width and Height. All fields are explicitly serialized, including null optional values. Name is the stored clinic legal/display name; when that value is blank or absent the snapshot freezes the neutral label **Clinic**. It does not make a live platform-tenant-name lookup. This fallback preserves finalization when clinic identity has not been configured; configure the intended legal name before rollout acceptance.

The logo is copied from the existing tenant-local sanitized PNG store, or explicitly recorded as null with null dimensions. There is no image URL, storage path, mutable logo reference or additional logo-copy store. Reprints use only this frozen object. No live branding resolver or logo conversion is invoked on read.

## Atomic signed and unsigned finalization

The necessary new source migration is [0105-prescription-branding-snapshot.sql](../../db/tenant-clinical/migrations/0105-prescription-branding-snapshot.sql), appended after 0104 in the tenant manifest. It changes only the two existing finalization procedure definitions; no new table, column, procedure contract parameter, grant or EF migration is introduced.

Both procedures retain existing patient, prescriber ownership, active Provider, Draft state, RowVersion and correction-review gates. Inside their existing transaction they validate the stored logo representation, read clinic/logo rows with transaction-held locks, build frozen branding, and append the versioned extension to the original clinical JSON before the original artifact insertion. State transition, artifact, finalization audit and any source supersession remain atomic. No historical artifact UPDATE or backfill exists in 0105.

Signed finalization keeps the same explicit confirmation and trusted signing instant. Unsigned finalization keeps its existing authorization and semantics; it does not acquire signing intent. Branding failure rolls back before any finalized state/artifact/audit success. Audit-failure tests also demonstrate rollback of both paths. A source comparison verified that both procedure bodies retain their preceding 0098 logic outside the explicit branding capture/version extension.

Migration 0105 was exercised only against the two uniquely named, disposable LocalDB databases created by the existing prescription fixture chain. The fixture uses verified tenant connection factories for both databases. No connection to `MicroEMR_LocalDev_Fresh`, production or another persistent application database occurred. Existing migration files were not edited.

## Logo and persistence safeguards

- Existing `ClinicLogoProcessor` is still the only upload decode/re-encode mechanism. Tests create synthetic images and pass them through that processor before snapshot capture.
- Existing storage limits remain **1 MiB**, with dimensions **1–2048** on each axis. SQL capture additionally rejects invalid PNG signature/IHDR/IEND structure or dimension mismatches; it relies on the existing upload processor for full canonical pixel sanitization.
- The snapshot adapter checks the base64 length before allocation, decoded byte limit, PNG structure, dimensions and consistent no-logo metadata. Unknown/missing new-version fields, unsupported content/signature markers and malformed branding fail closed; there is no silent fallback to legacy rendering or current branding.
- The maximum base64 payload is **1,398,104 characters**, plus bounded clinic/clinical metadata. Existing `ArtifactJson NVARCHAR(MAX)` accommodates it without schema expansion. A large canonical-PNG test verifies a payload above 700,000 bytes, JSON above 900,000 characters and exact stored-byte round-trip within the supported bounds.
- Rendering constructs an encoded data-URI image using the shared renderer; it does not decode/re-encode image pixels again. Existing Chromium JavaScript/service-worker/network restrictions remain intact. Text is HTML encoded, image aspect ratio is retained and no arbitrary external resource is fetched.

## PDF integration and clinical safeguards

`PrescriptionBrandingSnapshot` adapts the frozen header to the existing `ClinicPrintHeaderRenderer.Render`. It imports no global shared body/@page rules. Prescription-local styles constrain the repeated logo and clinic block. The version-3 path moves the existing Prescription title into that repeated header, without duplicate clinic identity/title, and keeps recorded patient context visible on continuation pages.

Signed body composition and the signature/preparer/requester/UTC/reference/page footer reuse the existing composer. Unsigned output reuses an extracted pure `ComposeArtifactHtml` method: the old legacy caller still receives the exact original HTML. Only the new unsigned branch moves its title and transmission notice to the page furniture and adds truthful output attribution plus **No electronic signature recorded**. It retains the prescriber block and every field supported by its original clinical layout.

Only version-3 layouts opt into measured header reservation. `PlaywrightPdfRenderer` measures the self-contained header fragment at Letter width and reserves its height plus spacing; it retains 0.65-inch sides and the existing 1.5-inch prescription footer/signature reservation. Older layouts keep their original margins/options. Headers exceeding the explicit four-inch measurement bound fail rather than clip or consume signature space. No referral, consultation, Scheduling or browser-print layout changed.

Directions, dates, dose/strength/route/frequency, quantity, refill count and independent refill quantity/unit/days remain independent original values. No SIG parsing/arithmetic, date recalculation, signature timestamp change, pharmacy metadata enrichment or private-note inclusion was added. Existing unsigned-layout limitations remain; this is branding, not a prescribing-content expansion. View/Print still opens the same generated-PDF endpoint.

## Authorization, tenant isolation and audits

Controllers, permission policies, actor resolution, roles and public endpoints are unchanged. Readers still require Patients.View; signing and unsigned finalization additionally require Prescriptions.Prescribe and their existing clinical checks. No consultation/document permissions were imported and no ClinicSettings.Manage prerequisite was introduced for readers.

Branding capture occurs through the same server-resolved tenant connection as finalization, within that tenant's database. Output fetches the patient/prescription-scoped artifact before rendering. Fresh endpoint tests show a patient-view-only reader can generate output, missing patient view is denied, prescribing-denied callers cannot sign or unsigned-finalize, and wrong-patient/other-tenant artifact access returns no document.

Existing finalization audits still commit with the artifact. `GenerateAsync` still awaits its output-generation audit before returning bytes. These events describe generation, not physical printing. No new public branding selector, request-supplied tenant, clinical actor or header payload is accepted.

## Verification results and requirement mapping

Latest outcomes are **69 distinct PASS, 0 remaining FAIL, 0 SKIP**: **13 new branding cases + 56 focused regressions**. Do not sum repeated executions as additional distinct tests.

| Requirement group | Evidence |
| --- | --- |
| L1–L7: historical compatibility | Pre-0105 legacy and version-2 fixtures remain readable; JSON unchanged after migration and reprints; identical legacy HTML/captured bytes and stable v2 body/header after branding edits. Existing refill/legacy SQL regressions pass. Native PDF metadata and v2 occurrence footer prevent a whole-PDF byte-identity claim; content/layout assertions are used instead. |
| N1–N8: new snapshots and immutability | Four signed/unsigned × logo/text-only cases verify version/content markers, frozen name/contact/canonical bytes, optional null contacts, signature presence/absence and unchanged stored JSON/RowVersion/body/header after logo/contact changes. New output requester changes only occurrence metadata. |
| N9–N10: size/atomicity | Large canonical PNG round-trip and oversize-reader rejection; invalid stored PNG and audit-failure rollback for both finalization paths. |
| A1–A8: security/audit | Real in-process endpoint authorization, correct-tenant capture and two-tenant isolation; existing owner/provider/RowVersion/signing/audit regressions. No controller/permission/public endpoint changes. |
| C1–C8: clinical preservation | Original SQL projection retained apart from the branding extension; assertions for directions, initial quantity, refill quantity/days/count and signature instant; reused clinical bodies/footers; existing print/refill assertions and native text/end markers. |
| P1–P9: layout and View/Print | Native logo/text-only/signed/unsigned/long-name/three-page PDFs; image proportions/count per page, glyph margins/footer boundary, repeated header/patient/signature/notices and all numbered clinical lines. Web View/Print endpoint is unchanged. |
| M1–M5: migration/compatibility | 0105 applies on both disposable tenants; old artifacts retained, both new paths persist correctly and procedure parameters remain unchanged. Old application version-3 dispatch was inspected explicitly; it is not compatible as a branded reader. |

The first new-test run failed in the test logo-save helper because a null binary row-version parameter was inferred as nvarchar. Corrected it to an explicitly typed binary parameter; recompiled only tests. The subsequent run had **12 PASS / 1 FAIL**: the native sample case exposed header measurement of the viewport/body rather than the fragment. Fixed that production measurement and completed an incremental affected build. A PDF-only rerun exposed a too-tight image-ratio assertion caused by Chromium rounding a 110px-wide image to whole pixels; corrected the test tolerance while retaining width/height limits. The final PDF-only case passed. All 56 regressions passed on their first run. Original receipts are retained.

Builds: isolated affected Application/Infrastructure/API/Web/DatabaseTool/test references compiled successfully, **zero warnings/errors**. A production incremental correction pass and test-only corrections also passed with zero warnings/errors. No full solution/certification suite, unrelated Step 01/02 tests, persistent migration or deployment preflight ran. Packages came from the existing cache; NuGet audit was disabled only for the offline restore.

```powershell
dotnet restore tests/MicroEMR.Api.Tests/MicroEMR.Api.Tests.csproj --artifacts-path .tmp/product-improvement-009/step03/artifacts --ignore-failed-sources -p:NuGetAudit=false
dotnet build tests/MicroEMR.Api.Tests/MicroEMR.Api.Tests.csproj --no-restore --artifacts-path .tmp/product-improvement-009/step03/artifacts
# Test-only corrections use --no-dependencies -p:BuildProjectReferences=false.
dotnet test tests/MicroEMR.Api.Tests/MicroEMR.Api.Tests.csproj --no-build --no-restore --artifacts-path .tmp/product-improvement-009/step03/artifacts --filter 'FullyQualifiedName~PrescriptionBrandingTests' --logger 'trx;LogFileName=prescription-branding-corrected.trx' --results-directory .tmp/product-improvement-009/step03/results
# After the corrections, rerun only the affected native-PDF method:
dotnet test tests/MicroEMR.Api.Tests/MicroEMR.Api.Tests.csproj --no-build --no-restore --artifacts-path .tmp/product-improvement-009/step03/artifacts --filter 'FullyQualifiedName~PrescriptionBrandingTests.NativePdfSamplesPreserveContentAndClearHeaderAndSignatureAreas' --logger 'trx;LogFileName=prescription-branding-pdf-corrected.trx' --results-directory .tmp/product-improvement-009/step03/results
dotnet test tests/MicroEMR.Api.Tests/MicroEMR.Api.Tests.csproj --no-build --no-restore --artifacts-path .tmp/product-improvement-009/step03/artifacts --filter 'FullyQualifiedName~PrescriptionPrintTests|FullyQualifiedName~PrescriptionPdfLayoutTests|FullyQualifiedName~PrescriptionRefillInstructionsTests|FullyQualifiedName~PrescriptionRefillSqlTests|FullyQualifiedName~PatientPrescriptionFoundationTests' --logger 'trx;LogFileName=prescription-regressions.trx' --results-directory .tmp/product-improvement-009/step03/results
```

## Synthetic samples and visual review

Samples are under `.tmp/product-improvement-009/step03/`, generated from disposable synthetic fixture snapshots through the existing renderer:

| PDF | Pages | Purpose |
| --- | ---: | --- |
| prescription-legacy.pdf | 1 | Original unbranded legacy reprint layout |
| prescription-signed.pdf | 1 | Version-3 signed, frozen canonical logo and signature |
| prescription-unsigned.pdf | 1 | Version-3 unsigned, original clinical body and no signature claim |
| prescription-text-only.pdf | 1 | No logo, missing optional phone/fax/email |
| prescription-long-clinic.pdf | 1 | Long legal name wrapping without overlap |
| prescription-multipage.pdf | 3 | Forty separate direction lines plus forty pharmacist-note lines, all retained |

All **eight pages** were rasterized with the already available Windows.Data.Pdf utility and visually inspected in this session. Logo proportions, title/clinic spacing, clinical labels, separated refills, signature/footer clearance, continuation and pagination were readable; no clipping or overlap was found. Automated checks independently verify text, glyph bounds, repeated furniture and embedded image counts. `pdf-results.json` and `pdf-image-rendering.json` retain counts; `{sample}-page-{number}.png` contains each raster page. This is local synthetic PDF review, not owner/live-browser/printer acceptance.

## Deployment and previous-version rollback matrix

No rollout was performed. A future authorized rollout must install a **version-3-capable reader before enabling migration 0105's new snapshot creation**, coordinating compatible API/Web Application/Infrastructure artifacts and retaining existing Chromium and baseline 0104. Pause finalization during any incompatible transition. No new client asset or package is required. Persistent SQL procedure dependency/ownership-chain permissions and actual deployment identity must be checked then; this task issues no grant or runtime permission claim.

| Application / snapshot or schema | Compatibility |
| --- | --- |
| Previous application + legacy/v2 snapshots | Existing support unchanged |
| New application + old schema/snapshots | Existing finalization contracts remain usable; old procedures continue creating old shapes until 0105 is applied; reader handles old shapes |
| New application + 0105 + v3 snapshots | Locally tested for signed and unsigned finalization/output |
| Previous application + existing v3 JSON | JSON can be retrieved/parsed, but old `== 2` dispatch falls into legacy rendering: branding and signed layout are not preserved. **Unsafe output downgrade** |
| Previous application after 0105 | Finalization parameters still match, but it can create v3 that its own output path mishandles. **Not a safe operational rollback** |

Unknown branding fields alone do not establish compatibility. After any v3 issuance, rollback must retain a v3-capable reader; do not revert to the preceding reader, delete new artifacts or downgrade JSON. No destructive reverse migration was prepared.

## Files, remaining risks and stop point

Files changed/added by this task:

- `src/MicroEMR.Application/PatientPrescriptions/PrescriptionOutputService.cs` — explicit v3 dispatch and opt-in layout flag.
- `src/MicroEMR.Application/PatientPrescriptions/PrescriptionBrandingSnapshot.cs` — bounded frozen-header adapter and v3 composition.
- `src/MicroEMR.Application/PatientPrescriptions/PatientPrescriptionModels.cs` — extract unchanged legacy HTML for reuse; old rendering path retained.
- `src/MicroEMR.Infrastructure/ClinicalOutput/PlaywrightPdfRenderer.cs` — v3-only measured header reservation.
- `db/tenant-clinical/migrations/0105-prescription-branding-snapshot.sql` and `db/tenant-clinical/manifest.json` — future atomic snapshot capture, source only.
- `tests/MicroEMR.Api.Tests/PrescriptionBrandingTests.cs` — 13 new cases, reusable fixture composition and native samples.
- This report.

Scoped source review compared **747** pre-existing source checksums against the prior tested PDBs: only the three expected existing production files differ; the branding adapter is new. Both finalization bodies were compared with 0098 outside their explicit new extension. Focused whitespace/source-link/manifest checks passed. Existing assessment, migrations, clinical records, referral/consultation code, Scheduling and owner changes were preserved.

**No critical local blocker remains.** Deferred acceptance requires a separately authorized compatible deployment/migration followed by actual development-tenant signed/unsigned output, patient-view-only access, tenant isolation, logo-change reprint checks, worst combined contact lengths and browser/PDF-viewer print review using approved fixtures. Existing Step 02 qualifications are not resolved here. PDF bytes remain dynamically generated, with expected metadata/occurrence differences; the preservation guarantee is frozen clinical/branding inputs and compatible rendering, not stored-byte identity. Large embedded logos increase artifact storage; unusually tall headers fail closed at the documented bound. Successful local tests do not establish production permissions or external certification acceptance.

**SATISFIED — LOCALLY VERIFIED. STOPPED.** No persistent migration, grant, clinical mutation, deployment/restart, commit/push or Step 03C/04 work occurred.

## Authorized development deployment and runtime follow-up

2026-11-01 (America/Toronto). The owner reported applying 0105 to `local-dev-fresh` and `local-dev`, then explicitly authorized deployment after inspection found the running API/Web still used Step 02 binaries. **DEPLOYED — PARTIALLY RUNTIME VERIFIED.** This section supersedes the preceding no-deployment checkpoint while retaining its local verification evidence.

### Verified deployment

- Matched **748 source checksums** to the tested Step 03 build before rollout; reused the build with the existing 69 distinct passing cases. No rebuild or test-suite rerun was needed.
- Read-only `local-dev-fresh` preflight verified database/tenant identity, migration 0105 ledger/version/source hash and both exact installed finalization definitions. Hash: `0485DD8CE3666F9A75C65BD5323AC2491C13AE11A82784BDF910CF2DC2286B08`. There were **three prior prescription artifacts and zero v3 artifacts** at preflight. No migration or SQL grant was applied by this task.
- Preserved and hash-verified **14** current API/Web DLL/PDB/static-asset metadata files and recorded configuration, Auth identity and Scheduling asset hashes. The first copy attempt encountered a residual DLL lock after stopping the two hosts; all 14 targets were independently confirmed unchanged. Once the lock was released, resumed verified copying and started API/Web. No second version was built or deployed.
- Deployment completed at **18:35:30 UTC / 13:35:30 America/Toronto**. Running API/Web PIDs: **9436 / 13140**. Verified loaded module paths/hashes, all 14 deployed/backup hashes, Development startup/content roots, unchanged configuration and Scheduling assets. Auth was not restarted. API `/health/platform` returned **200** and unauthenticated Web Clinic Settings **302**; startup stderr was empty.
- Previous binaries are retained for diagnosis, **not as a safe reader rollback**. Migration 0105 is installed and v3 fixtures now exist. Recovery/rollback must retain a v3-capable reader; no downgrade, artifact deletion or reverse migration was attempted.

### Runtime fixture scope and results

The owner signed in normally as `admin@microemr.local` and selected the verified `local-dev-fresh` tenant. Reused an existing synthetic development patient and the current administrator's active Provider mapping. Preserved existing prescriptions; created **three new clearly labelled synthetic runtime drafts through the normal Web/API**, then exercised only those drafts. No patient, user, Provider, role or membership was created or changed.

| Fixture / check | Observed result |
| --- | --- |
| `TEST ONLY 009 STEP03 RUNTIME SIGNED 20261101-1838`, UID `25F07EAF-38EF-4B30-BD86-B39505EDDC26` | **PASS** — authenticated explicit signing finalized version 3 / content version 2 / signature version 1, signer UserId 2 and trusted signing time. Branded PDF returned 200 with the expected logo, clinical fields, signature and generation footer. |
| `TEST ONLY 009 STEP03 RUNTIME UNSIGNED 20261101-1838`, UID `DDA9ACB6-D576-43A8-8C35-B53CA3183432` | **PASS** — unsigned finalization produced version 3 / content version 1 with no signature marker, signer or signing time. Branded PDF returned 200, retained the unsigned clinical layout and stated no electronic signature recorded. |
| `TEST ONLY 009 STEP03 RUNTIME TEXT 20261101-1838`, UID `E73287BD-B017-492C-A6C0-C001D9F519BF` | **PASS** — after restoring no-logo settings, explicit signing finalized version 3 with null logo/dimensions. Text-only PDF returned 200 with clinical content and signature intact. |
| Frozen branding after removal | **PASS** — both branded snapshots retain identical JSON hashes after current logo removal; both reprints retain one embedded logo and identical header/clinical text above the occurrence footer. Whole PDF bytes differ as expected for new output occurrences. |
| Historical downloads | **PASS** — all three pre-existing artifacts (two legacy, one v2) returned PDFs through the deployed reader. All three stored JSON hashes remain unchanged. No historical enrichment, artifact replacement or PDF-byte preservation claim. |
| Wrong patient | **PASS** — the new signed prescription UID under a different existing patient returned 404. |
| Repeat/stale signing | **PASS at API/state boundary** — retrying the finalized test prescription with its original draft row version returned API **409**, recorded a denial and created no second finalization. The Web action retains its existing generic error message. |
| Branding restoration | **PASS** — temporary `DEV TEST A` logo upload/removal used the normal audited Clinic Settings workflow. Original no-logo state restored and logo endpoint returned 404; contacts were not edited. |

The **three finalized test prescriptions remain as synthetic audited history**, not deleted or disguised as pre-existing records. Exactly one `PrescriptionDraftCreated` and one `PrescriptionFinalized` event exists for each under UserId 2. Five successful output-generation events for the new fixtures correspond to the two before/after branded reads and one text-only read. Normal historical generation/read and security-denial events are retained.

Runtime snapshot/PDF checks preserve the submitted 2026-11-01 written date, synthetic directions, initial quantity 10, refill count 2, independent refill quantity 60 and refill days 20. Signed metadata remains separate from current requester/occurrence metadata. Unsigned output preserves the original unsigned content boundary; no unsupported clinical field was newly inferred or added.

### PDF and integrity evidence

New runtime files in `.tmp/product-improvement-009/step03-rollout/`:

- `runtime-signed-branded.pdf`, `runtime-unsigned-branded.pdf`.
- `runtime-signed-restored.pdf`, `runtime-unsigned-restored.pdf`, `runtime-text-only-restored.pdf`.
- Three `historical-{prescriptionUid}.pdf` downloads.

All five new runtime PDFs have one page; expected embedded image counts are 1/1/1/1/0. PdfPig checks verify frozen header/clinical text equality across logo removal, clinical/refill/date text, signature semantics, logo proportions, per-page furniture and glyph/footer boundaries. All five pages were rasterized with Windows.Data.Pdf. Visually inspected the three final/restored outputs for logo/contact/title spacing, readable clinical/refill content, signature/footer clearance and unsigned semantics; no defect was found in those inspected pages. The two original branded pages were covered by automated checks and frozen-text comparisons. This is runtime PDF verification, not confirmation of physical printer output.

Closure independently verifies:

- **Eight existing prescription rows:** identical RowVersion and status, including all existing drafts.
- **Three historical prescription snapshots:** identical SHA256 of stored JSON.
- **Two new branded snapshots:** identical JSON hashes before/after logo removal.
- **Twelve unrelated hash groups:** unchanged clinic profile/contacts, patient documents, encounters, referrals, artifact metadata/files, stored referral bytes, memberships, appointments/history, scheduling resources/preferences.
- Original no-logo state restored with exactly two intended branding audit events; its row version correctly advances.
- Five pre-existing missing historical filesystem files remain **5 → 5**; none was repaired or regenerated.

Evidence includes `preflight.json`, `plan-and-rollback.json`, `deployment.json`, `versions.json`, `health.json`, fixture/finalization/download receipts, prescription/snapshot/audit baseline/closure JSON, `pdf-verification.json`, page images and `closure.json`. SQL helpers under `.tmp/status-acceptance-preparation/009-step03-*.fsx` are read-only. All persistent fixture/branding mutations went through existing authenticated Application/API/stored-procedure workflows.

Helper qualifications: the standalone prescription Create/Edit pages lack the shell tenant meta tag expected by the acceptance helper. Its pre-command checks stopped before logo/finalization writes until the original browser tab was returned to Clinic Settings; subsequent finalization commands restore that page themselves. The initial stale-signing helper expected a conflict-specific Web message, but the existing UI intentionally uses a generic message; API 409 and audit/state evidence establish the rejection. No application patch, authorization bypass or second deployment was made for these helper issues. The isolated acceptance browser was closed without exporting authentication sessions.

### Remaining qualifications

`local-dev-fresh` migration and the core signed/unsigned/no-logo workflows are independently verified. The owner-reported `local-dev` migration is **not independently verified**: catalog lookup through existing read procedures resolves it to `MicroEMR_Db` / `development:MicroEMR_Db`, but the corresponding DatabaseTool deployment secret alias is unavailable. Direct catalog SELECT was denied by the established principals; switched to the existing authorized read procedure without adding grants. No connection to that tenant database, migration, fixture or clinical mutation was performed by this task.

An actual patient-view-only reader, authenticated cross-tenant isolation, and deployed multipage/worst combined contact-length cases remain pending suitable approved sessions/fixtures. The 69 local tests retain their evidence for those boundaries; they are not promoted to deployed PASS. Existing Step 02 qualifications remain outside this rollout.

Only this report and ignored deployment/evidence helpers were written to the repository during the rollout; Step 03 implementation source/tests, owner assessment and other application files were preserved. No Git operation, build, persistent migration/grant, production access or Step 03C/04 work occurred. **DEPLOYED — PARTIALLY RUNTIME VERIFIED; core development workflows passed.**
